(Q34322848)

1 August 2017

1 reference

title

Psychosis treatment prior to psychosis onset: ethical issues (English)

1 reference

1 August 2017

0 references

1 reference

1

T H McGlashan

1 reference

PubMed ID

11479065

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

1 August 2017

Schizophrenia Research

1 reference

1 August 2017

51

1 reference

1 August 2017

1

1 reference

1 August 2017

47-54

1 reference

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Early intervention for first episodes of schizophrenia: a preliminary exploration

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Equipoise and the ethics of clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Community equipoise and the architecture of clinical research.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Early detection and intervention in schizophrenia: editor's introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Early detection and intervention in schizophrenia: research

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Treating schizophrenia earlier in life and the potential for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Schizophrenia as a disorder of developmentally reduced synaptic connectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Early detection and intervention with schizophrenia: rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Symptom assessment in schizophrenic prodromal states

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

Monitoring and care of young people at incipient risk of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900238-9

7 January 2021

10.1016/S0920-9964(01)00238-9

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11479065